EUVIMEDEUVIMED entdecken
Crossref

Comorbid diseases in bullous pemphigoid: A population‐based case–control study

Bo Ri Kim iD, Kun Hee Lee iD, Kyungho Paik iD, Minjae Kim iD, Jung Min Bae iD, Chong Won Choi iD, Sang Woong Youn iD

The Journal of Dermatology · 2025-03 · 52 (3) · 460-471

DOI: 10.1111/1346-8138.17577 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Dermatology, online erschienen am 13.12.2024. Verfasst von Bo Ri Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea. Hauptthemen laut MEDLINE: Pemphigoid, Bullous. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Seoul National University Bundang Hospital Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bullous pemphigoid (BP) is the most prevalent autoimmune blistering disorder, triggered by autoantibodies targeting hemidesmosome components. It is associated with substantial morbidity and increased mortality. No studies comprehensively evaluate all comorbidities before and after diagnosing patients with BP. We aimed to investigate all BP‐associated comorbid diseases and their patterns of associations. This nationwide population‐based study included 5066 patients with BP and 10 132 controls between 2011 and 2021. We performed an automated mass screening of 546 diagnostic codes to identify BP‐associated comorbidities 5 years before and after BP diagnosis, and analyzed associations patterns of comorbidities. Patients with BP had increased odds of having pressure ulcers, intracerebral hemorrhage, scabies, neuropsychiatric disorders, psoriasis, drug eruption, and acute renal failure before BP diagnosis. After BP diagnosis, they had increased odds pneumonia, sepsis, chronic renal disease, and cardiac arrest. Strong interrelationships were observed between five neuropsychiatric conditions before BP diagnosis and a strong bidirectional association between Alzheimer's dementia and pneumonia after BP diagnosis. This large case–control study of patients with BP thoroughly identified all relevant comorbidities before and after BP diagnosis, highlighting their clinical significance as predisposing and prognostic factors in patients with BP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pemphigoid, BullousHumansMaleCase-Control StudiesFemaleAgedComorbidityMiddle AgedAged, 80 and overAdultTaiwan

Stichwörter der Autor:innen

association rules analysisbullous pemphigoidcomorbiditymass screening

Autor:innen und Institutionen

  • Department of Dermatology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea.
  • Department of Applied Statistics, Yonsei University, Seoul, Republic of Korea.
  • Department of Dermatology, St Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

ORCID-Profile: Bo Ri Kim, Kun Hee Lee, Kyungho Paik, Minjae Kim, Jung Min Bae, Chong Won Choi, Sang Woong Youn

Förderung

  • Seoul National University Bundang Hospital Research Fund

Zitieren

APA

Kim, B. R., Lee, K. H., Paik, K., Kim, M., Bae, J. M., Choi, C. W., & Youn, S. W. (2025). Comorbid diseases in bullous pemphigoid: A population‐based case–control study. The Journal of Dermatology, 52(3), 460-471. https://doi.org/10.1111/1346-8138.17577

Vancouver

Kim BR, Lee KH, Paik K, Kim M, Bae JM, Choi CW, et al. Comorbid diseases in bullous pemphigoid: A population‐based case–control study. The Journal of Dermatology. 2025;52(3):460-471. doi:10.1111/1346-8138.17577

BibTeX
@article{Kim2025,
  author = {Kim, Bo Ri and Lee, Kun Hee and Paik, Kyungho and Kim, Minjae and Bae, Jung Min and Choi, Chong Won and Youn, Sang Woong},
  title = {Comorbid diseases in bullous pemphigoid: A population‐based case–control study},
  journal = {The Journal of Dermatology},
  year = {2025},
  volume = {52},
  number = {3},
  pages = {460--471},
  doi = {10.1111/1346-8138.17577}
}
Kostenlos starten →